Dr. Jur Strobos has been appointed chief medical officer of InNexus Biotechnology, Inc. Dr. Strobos has extensive experience as director of policy research in the office of the Commissioner of the FDA and has a background in drug law, medical product development, and health care. Most recently, he was vice president of clinical research and regulatory affairs for Medicis Pharmaceutical Corp.
His areas of expertise include food and drug law, clinical study design and good manufacturing practices. He has been involved in the success of multiple drugs and devices through the FDA and will be working closely with Dr. Thomas Kindt, InNexus' chief scientific officer and previous director of Intramural Research at the National Institute of Health.
Dr. Kindt said, "Dr. Strobos joins InNexus as we prepare to launch our first pre-clinical development project. His experience is invaluable and his ability to develop our programs and articulate them to the FDA will be a critical aspect of our success."